ELAROS partners in £3.4M NIHR study into Long COVID Treatment Pathways

ELAROS is proud to announce its involvement in the LOCOMOTION (LOng COvid Multidisciplinary consortium: Optimising Treatments and servIces acrOss the Nhs) study, a £3.4 million project led by The University of Leeds which is funded by the National Institute for Health Research (NIHR). The study, led by Dr Manoj Sivan, aims to establish a gold standard of care for the treatment of Long COVID patients that can be used across the whole of the UK. 

The research consortium includes 8 UK Universities including Imperial College, King’s College, The University of Oxford, and 10 clinical sites across all 4 UK nations, with ELAROS named as an industrial partner that will provide the C19-YRS app and research platform to all 10 research sites. The aim is to gather large amounts of patient data quickly to help the consortium devise ways of supporting the nearly 2 million Long Covid patients in the UK, and to further validate the C19-YRS scale to develop a standardised approach.